[JANX] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -66.33%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 8,083 8,612 3,637 0 0 -
PBT -58,293 -63,059 -32,672 -6,784 -4,004 95.24%
Tax 0 -8,905 -113 -1,529 233 -
NP -58,293 -54,154 -32,559 -5,255 -4,237 92.50%
Tax Rate - - - - - -
Total Cost 66,376 62,766 36,196 5,255 4,237 98.85%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -721.18 -628.82 -895.22 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.32 -1.31 -0.79 -0.13 -0.10 90.52%
EPS Diluted -1.32 -1.31 -0.79 -0.13 -0.10 90.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.